// App-Quantinova.ai

: USE OF DIRECT ORAL ANTICOAGULANTS AS PRIMARY OR SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH MULTIPLE MYELOMA ON IMMUNOMODULATORY DRUGS

Researchers

Presenter

  • Carlos Aguilar

Principal Investigators

  • Ana Dueas

  • Fernando Sevil

  • Carlos Dominguez

  • veronica campuzano

Medical Centers

  • Oncology,Hospital General Santa Bárbara,Soria,Spain

  • Hematology Service, Hospital Universitario de Burgos, Burgos, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Enoxaparin

  • Enoxaparin sodium

  • apixaban

  • Edoxaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved